Robert Baffi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Novato, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Donna M. Cochener as attorney-in-fact for Robert Baffi
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Baffi

Form 4 holding Director

Neurogene Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
12,050
Estimated value
Report date
20 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mosaic ImmunoEngineering Inc.

Security class
Convertible Note
Shares / value
$50,000
Estimated value
Report date
18 Feb 2022
Price
Ownership
Direct
Underlying class
See footnotes
Underlying amount

Insider Reports Filed by Robert Baffi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .